Multicentre open-label randomised controlled trial to evaluate the efficacy and safety of moderate-dose and high-dose intravenous methylprednisolone combined with plasmapheresis versus plasmapheresis alone in leptospirosis pulmonary haemorrhage syndrome: a protocol.
- DOI
- 10.1136/bmjopen-2026-119234
- Published
- 2026 Aug 3
- Container
- BMJ open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bmjopen-2026-119234,
title = {Multicentre open-label randomised controlled trial to evaluate the efficacy and safety of moderate-dose and high-dose intravenous methylprednisolone combined with plasmapheresis versus plasmapheresis alone in leptospirosis pulmonary haemorrhage syndrome: a protocol.},
author = {Yeshinika KA and Vidanapathirana S and Rambukwella R and Uluwattage W and Mudalige AD and Wanigasuriya R and Jeewandara C and Priyankara D and Perera N},
year = {2026},
journal = {BMJ open},
doi = {10.1136/bmjopen-2026-119234},
url = {https://doi.org/10.1136/bmjopen-2026-119234}
}RIS
TY - JOUR TI - Multicentre open-label randomised controlled trial to evaluate the efficacy and safety of moderate-dose and high-dose intravenous methylprednisolone combined with plasmapheresis versus plasmapheresis alone in leptospirosis pulmonary haemorrhage syndrome: a protocol. AU - Yeshinika KA AU - Vidanapathirana S AU - Rambukwella R AU - Uluwattage W AU - Mudalige AD AU - Wanigasuriya R AU - Jeewandara C AU - Priyankara D AU - Perera N PY - 2026 JO - BMJ open DO - 10.1136/bmjopen-2026-119234 UR - https://doi.org/10.1136/bmjopen-2026-119234 ER -
APA
KA, Y., S, V., R, R., W, U., AD, M., R, W., C, J., D, P., & N, P. (2026). Multicentre open-label randomised controlled trial to evaluate the efficacy and safety of moderate-dose and high-dose intravenous methylprednisolone combined with plasmapheresis versus plasmapheresis alone in leptospirosis pulmonary haemorrhage syndrome: a protocol.. BMJ open. https://doi.org/10.1136/bmjopen-2026-119234
Source records
- pubmed · retrieved 2026-09-25T21:44:30.758Z